ClearBridge Investments
MRNA icon

ClearBridge Investments’s Moderna MRNA Stock Holding History

ClearBridge Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-53,264
Closed -$8.18M – 713
2023
Q1 		$8.18M Sell
53,264
-10
-0% -$1.65K 0.01% 525
2022
Q4 		$9.57M Buy
+53,274
New +$8.71M 0.01% 521
2020
Q3 		– Sell
-1,000
Closed -$64K – 909
2020
Q2 		$64K Buy
+1,000
New +$54.8K ﹤0.01% 773

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments's MRNA Position: Q2 2023 in Review

ClearBridge Investments sold out of Moderna (MRNA) in Q2 2023, closing a stake of 53,264 shares — an estimated $8.18M sold.

ClearBridge Investments first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $9.57M in Q4 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • ClearBridge Investments reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • ClearBridge Investments sold 53,264 Moderna shares in Q2 2023, an estimated $8.18M.
  • ClearBridge Investments first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
  • ClearBridge Investments's Moderna position peaked at $9.57M in Q4 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on ClearBridge Investments's 13F filing for Q2 2023, filed 11 Aug 2023.